Amylyx Pharmaceuticals · 5 months ago
Medical Director, Clinical Development
Amylyx is a clinical-stage pharmaceutical company dedicated to developing novel therapies for high unmet needs. They are seeking a Medical Director, Clinical Development to lead pivotal programs and oversee clinical trials, ensuring the integrity of studies and collaboration with various stakeholders. The role involves medical monitoring, clinical development leadership, and interaction with global medical experts and regulatory authorities.
BiotechnologyMedicalNeurosciencePharmaceutical
Responsibilities
Provides medical monitoring to assigned clinical trials in the arenas of serious endocrine conditions
Provides clinical development leadership for programs that integrate extensive knowledge in clinical science and endocrinology, and inputs from the global medical and patient communities
Works closely with Medical Directors, Pharmacology, Drug Discovery, external experts, and investigators to accumulate scientific and medical knowledge necessary to support clinical development plans
Integrates scientific rationale, regulatory requirements, product development plan, and value to patients and shareholders to build a solid Clinical Development Plan (CDP)
Accountable for production of highest quality program related documents, including protocols, IBs, clinical study reports, briefing documents and drug labels
Develops and maintains relationships with program counterparts in Research, Regulatory Affairs, Clinical Operations, Statistics and Contract Research Organizations (CROs)
Acts as the primary Clinical Development interface with internal stake holders as well as external subject matter experts and alliance partners for the assigned programs
Contributes to specific Business Development activities and various organizational initiatives in Clinical Development
Qualification
Required
MD required
Experience with late-stage clinical development and drug development in rare diseases strongly preferred
4+ years of experience in leading clinical development programs in the biotechnology/pharmaceutical industry with a proven record of achievements
Ability to think critically and demonstrate troubleshooting and problem-solving skills
Demonstrated leadership and team building skills as well as the ability to perform effectively in a multi-disciplinary environment
Ability to lead directly and by influence, including strong interpersonal, problem solving, conflict resolution and analytical skills in a matrix environment
Excellent communication skills (oral and written) and organizational skills
Ability to travel internationally and domestically
Company
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Funding
Current Stage
Public CompanyTotal Funding
$623.45MKey Investors
Viking Global InvestorsMorningside
2025-09-10Post Ipo Equity· $175M
2022-10-06Post Ipo Equity· $246.3M
2022-01-07IPO
Recent News
BioWorld Financial Watch
2026-01-11
Longevity.Technology
2026-01-11
Company data provided by crunchbase